Glucose control in overnight-only closed-loop control (CLC) mode	Glucose control in 24/7 closed-loop control (CLC) mode	Serious adverse events	20313	20429	There were no cases of severe hypoglycemia, diabetic ketoacidosis, or other serious adverse events during the trial.
Glucose control in overnight-only closed-loop control (CLC) mode	Glucose control in 24/7 closed-loop control (CLC) mode	Daytime mean glucose	19641	19842	Daytime mean glucose; median time in target, 70â€“180 mg/dL; and median time >180 mg/dL were not significantly different (P = 0.07, 0.49, and 0.61 respectively) comparing 24/7 CLC and overnight-only CLC.
